CRESCENT BIOPHARMA INC (CBIO:NASDAQ)
$17.6 0.6 (3.5294%)
Analysed CRESCENT BIOPHARMA INC (CBIO:NASDAQ) News Sources
Crescent Biopharma to Present at March Investor Conferences
23-02-2026
yahoo.com
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
26-02-2026
yahoo.com
Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights
29-04-2026
yahoo.com
Crescent Biopharma to Present at May Investor Conferences
06-05-2026
yahoo.com
Crescent Biopharma to Present at June Investor Conferences
02-06-2026
yahoo.com
Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
30-07-2026
yahoo.com
Crescent Biopharma Announces Grants of Inducement Awards
26-06-2026
yahoo.com
Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
14-07-2026
yahoo.com
Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants
15-07-2026
yahoo.com
Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
16-07-2026
yahoo.com
What is the current price of CRESCENT BIOPHARMA INC (CBIO:NASDAQ)?
The current price of CRESCENT BIOPHARMA INC (CBIO:NASDAQ) is $17.6.
CRESCENT BIOPHARMA INC (CBIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of CRESCENT BIOPHARMA INC (CBIO:NASDAQ) since the previous trading day is $0.6.
CRESCENT BIOPHARMA INC (CBIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of CRESCENT BIOPHARMA INC (CBIO:NASDAQ) since the previous trading day is 3.5294%.
What is the most recent average sentiment score for CRESCENT BIOPHARMA INC (CBIO:NASDAQ)?
The most recent average sentiment score for CRESCENT BIOPHARMA INC (CBIO:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for CRESCENT BIOPHARMA INC (CBIO:NASDAQ)?
The most recent sentiment for CRESCENT BIOPHARMA INC (CBIO:NASDAQ) is .
SEC-8K** Filing Available For CRESCENT BIOPHARMA INC (CBIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.